Document Detail

Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis.
MedLine Citation:
PMID:  21529304     Owner:  NLM     Status:  In-Data-Review    
Morning joint stiffness and pain are prominent features in patients suffering from rheumatoid arthritis (RA) and contribute to impaired function. A survey was conducted across 11 European countries to assess the impact of impaired morning function on patients' quality of life. A total of 518 rheumatologists, and 750 patients aged 18-75 years with RA for ≥ 6 months and impaired morning function at least three times a week, completed the structured questionnaires. Impaired morning function was defined as 'stiffness and pain in the joints first thing in the morning that results in difficulty to function or perform tasks'. The mean duration of morning stiffness and pain was 83 min according to patients, slightly longer than that estimated by rheumatologists (70 min). Impaired morning function lasting more than 30 min/day was reported by 75% of patients, with 76% of rheumatologists estimating this duration for their patients. Most respondents (82% of patients and 96% of rheumatologists) considered that impaired morning function had a significant effect on patient quality of life. Around two-thirds of patients reported changes in how they carry out usual morning activities. Patients who were unable to function normally in the morning reported feeling frustrated (58%) and angry (32%). Almost one in five patients in the survey (18%) was unable to work as a direct result of their RA. Of the 274 patients included in the survey who were in paid work, 73% reported that impaired morning function had a significant impact on their job; 40% missed time from work in the past 6 months due to impairment in morning function, resulting in a mean of 4.5 days lost from work/employed person. In conclusion, the survey shows that impaired morning function has a considerable impact on the lives and well-being of patients with RA.
Jap da Silva; S Phillips; F Buttgereit
Related Documents :
11418374 - Pharmacokinetic evaluation of recombinant, activated factor vii in patients with inheri...
7893924 - Coagulation factors and markers of activation of coagulation in homocystinuria (hocy): ...
2133234 - Fibrinogen lima. a new dysfibrinogenaemia with a high-molecular-weight alpha-chain and ...
1521824 - Factor viii concentrates in hiv-1-positive hemophiliacs--is pure better?
7436054 - Hymenoptera venom allergy: a geographic study.
8677944 - Increased prevalence of aortic calcification in chronic pancreatitis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of rheumatology. Supplement     Volume:  125     ISSN:  1502-7740     ISO Abbreviation:  Scand. J. Rheumatol. Suppl.     Publication Date:  2011  
Date Detail:
Created Date:  2011-05-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400360     Medline TA:  Scand J Rheumatol Suppl     Country:  England    
Other Details:
Languages:  eng     Pagination:  6-11     Citation Subset:  IM    
Department of Rheumatology, Coimbra University Hospital , Coimbra , Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease.
Next Document:  How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?